C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2
- 11 January 2010
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 129 (1) , 32-38
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- DNA epitope vaccine containing complement component C3d enhances anti-amyloid-β antibody production and polarizes the immune response towards a Th2 phenotypeJournal of Neuroimmunology, 2008
- Retracted: Construction, Expression and Immunoassay Detection of Recombinant Plasmid Encoding Fusion Protein of Roman Chicken Complement C3d and Newcastle Disease Virus F geneScandinavian Journal of Immunology, 2008
- Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complexCurrent Opinion in Immunology, 2005
- DNA immunization with plasmids expressing hCGβ-chimerasVaccine, 2004
- Mouse strain-dependent differences in enhancement of immune responses by C3dVaccine, 2004
- Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse modelVaccine, 2004
- Fusion to C3d Enhances the Immunogenicity of the E2 Glycoprotein of Type 2 Bovine Viral Diarrhea VirusJournal of Virology, 2004
- Structure of Complement Receptor 2 in Complex with Its C3d LigandScience, 2001
- C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired ImmunityScience, 1996
- Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.Journal of Experimental Medicine, 1983